This inventor holds 1 USPTO granted patent. Top assignees: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts, Transgene S.a.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 168 
1 out of 159 
Years Active: 2006
Title: Dirk Grimm: Innovator in AAV Technology
Introduction
Dirk Grimm is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of gene therapy, particularly through his work on adeno-associated virus (AAV) technology.
Latest Patents
Dirk Grimm holds a patent for "AAV DNA comprising helper virus sequences." This invention relates to an AAV DNA that includes helper virus sequences essential for developing AAV viral particles. The patent also covers a system containing such DNA and its various applications.
Career Highlights
Throughout his career, Dirk Grimm has worked with prestigious organizations, including the German Cancer Research Center (Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts) and Transgene S.A. His work has been pivotal in advancing the understanding and application of AAV in therapeutic contexts.
Collaborations
Dirk has collaborated with esteemed colleagues such as Jürgen Kleinschmidt and Karola Rittner. These partnerships have fostered innovation and have contributed to the success of his research endeavors.
Conclusion
Dirk Grimm's contributions to AAV technology and his collaborations with other experts highlight his role as a significant figure in the field of gene therapy. His work continues to influence advancements in medical science and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile